The role of gender in predicting for reduced drug clearance and increased toxicity in non-small cell lung cancer (NSCLC) patients receiving carboplatin and paclitaxel.
V. H. Phan
No relevant relationships to disclose
C. Tan
No relevant relationships to disclose
J. L. Vardy
No relevant relationships to disclose
A. Rittau
No relevant relationships to disclose
H. Xu
No relevant relationships to disclose
F. Zhang
No relevant relationships to disclose
A. J. McLachlan
No relevant relationships to disclose
P. J. Beale
No relevant relationships to disclose
S. J. Clarke
No relevant relationships to disclose